NEXTURNBIOSCIENCE Co., Ltd.

Informe acción KOSDAQ:A089140

Capitalización de mercado: ₩38.9b

NEXTURNBIOSCIENCE Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Young-Hwa Jung

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) Shares Climb 33% But Its Business Is Yet to Catch Up

NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Oct 17
NEXTURNBIOSCIENCE Co., Ltd.'s (KOSDAQ:089140) 33% Price Boost Is Out Of Tune With Revenues

Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

Aug 13
Does NEXTURNBIOSCIENCE (KOSDAQ:089140) Have A Healthy Balance Sheet?

NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Mar 28
NEXTURNBIOSCIENCE's (KOSDAQ:089140) Attractive Earnings Are Not All Good News For Shareholders

Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

Jan 25
Shareholders Of NexturnLtd (KOSDAQ:089140) Must Be Happy With Their 119% Total Return

CEO

Young-Hwa Jung (65 yo)

no data

Permanencia

Mr. Jung Young-Hwa serves as the Chief Executive Officer of NexturnBioscience Co., Ltd (formerly known as Nexturn Co.,Ltd.)